Skip to content

TIVC

Valion Bio, Inc.

NASDAQ · Healthcare · Medical - Devices · US

$0.26
−10.46%
Ask drillr
0
Insider buys (3m)
0
Insider sells (3m)
$0.00
Net value (3m)
-81.0%
Price return (3m)
Form 4 filings
DateInsiderActivitySharesPrice
Apr 20, 2026Bolton Sheryle · directorPurchase10,000$1.04
Apr 2, 2026Valauri Christina Rizopoulos · directorPurchase19,000$0.95
Mar 19, 2026Wolf Lisa G · officer: Chief Financial OfficerM-Exempt92$0.00
Feb 20, 2026Handley Michael K · officer: Chief Operating OfficerM-Exempt8,824$0.00
Dec 22, 2025Wolf Lisa G · officer: Chief Financial OfficerM-Exempt736$0.00
Dec 22, 2025Ernst Jennifer · director, officer: Chief Executive OfficerF-InKind5,262$1.87
Dec 22, 2025Ernst Jennifer · director, officer: Chief Executive OfficerM-Exempt14,706$0.00
Dec 22, 2025Wolf Lisa G · officer: Chief Financial OfficerF-InKind302$1.87
Sep 24, 2025Ernst Jennifer · director, officer: Chief Executive OfficerA-Award22,541$0.00
Aug 8, 2025Ernst Jennifer · director, officer: Chief Executive OfficerA-Award85,000$3.32
Aug 8, 2025Bolton Sheryle · directorA-Award12,500$3.32
Aug 8, 2025Handley Michael K · officer: Chief Operating OfficerA-Award45,000$3.32
Aug 8, 2025Valauri Christina Rizopoulos · directorA-Award7,500$3.32
Aug 8, 2025Wolf Lisa G · officer: Chief Financial OfficerA-Award80,000$3.32
Aug 8, 2025Zikria Dean · directorA-Award7,500$3.32
Feb 24, 2025Handley Michael K · officer: Chief Operating OfficerA-Award600,000$0.00
Dec 20, 2024Bolton Sheryle · directorA-Award15,000$0.23
Dec 20, 2024Valauri Christina Rizopoulos · directorA-Award12,000$0.23
Dec 20, 2024Wolf Lisa G · officer: Interim CFOA-Award25,000$0.00
Dec 20, 2024Zikria Dean · directorA-Award12,000$0.23
Dec 20, 2024Gurfein Blake · officer: Chief Scientific OfficerA-Award225,000$0.00
Dec 20, 2024Ernst Jennifer · director, officer: Chief Executive OfficerA-Award500,000$0.00
Aug 13, 2024Valauri Christina Rizopoulos · directorA-Award3,000$0.41
Aug 13, 2024Bolton Sheryle · directorA-Award3,000$0.41
Aug 13, 2024Zikria Dean · directorA-Award3,000$0.41
Aug 13, 2024Drexler Karen · directorA-Award3,000$0.41
Mar 22, 2024Gurfein Blake · officer: Chief Scientific OfficerA-Award10,000$1.34
Mar 22, 2024Ernst Jennifer · director, officer: Chief Executive OfficerA-Award32,000$1.34
Mar 22, 2024Bambach Kimberly Ann · officer: Interim CFOA-Award7,500$0.00
Jun 16, 2023Drexler Karen · directorA-Award25,000$0.09
Institutional positioning

13F filings over the trailing two quarters

New 10Increased 3Reduced 5Sold out 1
FilerActionSharesFiled
Murchinson Ltd.New Position115,000Aug 14, 2026
GEODE CAPITAL MANAGEMENT, LLCNew Position87,818May 15, 2026
CITADEL ADVISORS LLCNew Position74,145Sep 2, 2026
Sanctuary Advisors, LLCUnchanged61,205Aug 13, 2026
SANCTUARY ADVISORS, LLCNew Position61,205May 5, 2026
MAREX GROUP PLCIncreased59,263May 13, 2026
Marex Group plcReduced54,287Aug 14, 2026
HRT FINANCIAL LPNew Position42,419May 14, 2026
Virtu Financial LLCNew Position39,225Aug 13, 2026
GEODE CAPITAL MANAGEMENT, LLCReduced19,374Aug 12, 2026
HRT FINANCIAL LPReduced11,462Aug 14, 2026
UBS Group AGIncreased11,094Aug 13, 2026
XTX TOPCO LTDNew Position10,506May 15, 2026
TWO SIGMA SECURITIES, LLCNew Position10,162Aug 14, 2026
UBS GROUP AGReduced2,366May 5, 2026

Insider activity from SEC Form 4; institutional positioning from 13F filings · Latest filing Apr 20, 2026